BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9674708)

  • 1. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
    Karnik P; Chen P; Paris M; Yeger H; Williams BR
    Oncogene; 1998 Jul; 17(2):237-40. PubMed ID: 9674708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
    Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.
    Schofield DE; Beckwith JB; Sklar J
    Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
    Tran YK; Newsham IF
    Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor.
    Tamimi Y; Ziebart K; Desaulniers N; Dietrich K; Grundy P
    Genes Chromosomes Cancer; 2007 Apr; 46(4):327-35. PubMed ID: 17243164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis.
    Karnik P; Paris M; Williams BR; Casey G; Crowe J; Chen P
    Hum Mol Genet; 1998 May; 7(5):895-903. PubMed ID: 9536095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
    Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of methylation at chromosome 11p15.5 is common in human adult tumors.
    Scelfo RA; Schwienbacher C; Veronese A; Gramantieri L; Bolondi L; Querzoli P; Nenci I; Calin GA; Angioni A; Barbanti-Brodano G; Negrini M
    Oncogene; 2002 Apr; 21(16):2564-72. PubMed ID: 11971191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
    Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors.
    Miozzo M; Perotti D; Minoletti F; Mondini P; Pilotti S; Luksch R; Fossati-Bellani F; Pierotti MA; Sozzi G; Radice P
    Genomics; 1996 Nov; 37(3):310-5. PubMed ID: 8938443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel transcribed sequences within the BWS/WT2 region in 11p15.5: tissue-specific expression correlates with cancer type.
    Crider-Miller SJ; Reid LH; Higgins MJ; Nowak NJ; Shows TB; Futreal PA; Weissman BE
    Genomics; 1997 Dec; 46(3):355-63. PubMed ID: 9441738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelotype of pediatric rhabdomyosarcoma.
    Visser M; Sijmons C; Bras J; Arceci RJ; Godfried M; Valentijn LJ; Voƻte PA; Baas F
    Oncogene; 1997 Sep; 15(11):1309-14. PubMed ID: 9315099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
    Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.
    Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM
    Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.